SUMMARY Fifteen patients with definite multiple sclerosis were examined with high volume delayed (HVD) CT scan and positron emission tomography (PET) using 68-Ga-EDTA as a tracer. The passage of 68-Ga-EDTA across the blood-brain barrier (BBB) was measured by using multiple graphical analysis. This method permits the simultaneous calculation of a blood to brain influx constant Ki (ml/g-' min-1) and of the plasma volume Vp (ml/g-1). In postmortem perfusional studies utilising trypan blue, Broman first demonstrated a disturbance of blood-brain barrier (BBB) permeability in some multiple sclerosis plaques.1 Subsequently, using CT scan after the intravenous injection of a contrast medium, regions of abnormal enhancement, reflecting extravasation of iodine through a damaged BBB, have frequently been reported in patients with multiple sclerosis.24 The detection of these enhancing areas was found to be markedly increased when the patients were studied during recent clinical exacerbation' 6 and when a high volume delayed CT scanning technique (HVD-CT) was employed.78 However, enhanced CT shows only a BBB alteration without being able to quantify the alteration itself.
found in these pathological areas. Quantitative data obtained with PET seems to provide further insight into the study of BBB function in multiple sclerosis.
In postmortem perfusional studies utilising trypan blue, Broman first demonstrated a disturbance of blood-brain barrier (BBB) permeability in some multiple sclerosis plaques.1 Subsequently, using CT scan after the intravenous injection of a contrast medium, regions of abnormal enhancement, reflecting extravasation of iodine through a damaged BBB, have frequently been reported in patients with multiple sclerosis.24 The detection of these enhancing areas was found to be markedly increased when the patients were studied during recent clinical exacerbation' 6 and when a high volume delayed CT scanning technique (HVD-CT) was employed.78 However, enhanced CT shows only a BBB alteration without being able to quantify the alteration itself.
The measurement of BBB permeability in humans has recently been obtained using positron emission tomography (PET).9 -13 In a previous paper14 we described a simple and non invasive method for quantifying BBB permeability using 68-Ga-EDTA and PET. The technique was found to be sensitive and accurate for the measurement of BBB disruption associated with brain tumours.
The purpose of the present investigation was to elucidate the value of 68-Ga-EDTA and PET in the study of BBB abnormalities associated with multiple sclerosis.
Material and methods
Patients A total of 15 patients with multiple sclerosis, three men and 12 women, aged 17 to 51 years (mean 30 yr) and four age-matched control subjects were selected for the study. The diagnosis of definite multiple sclerosis was determined by the clinical criteria of Schumacher et al." CSF studies and evoked potentials were available in all patients. Magnetic resonance imaging was performed on five patients.
Eight patients experienced a clinical exacerbation at the time of the study; two were in remission and five had a chronic progressive form of multiple sclerosis. All patients had clinical or CT scan suggestion of at least one supratentorial area of the demyelinating process, although in the five patients with the chronic progressive form of the disease. the clinical decline was evidenced mainly by neurological 1058
Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and PET 1059 Additionally in all patients and in normal subjects, four standard ROIs were placed on the frontal and parietal lobes and averaged in order to obtain a whole-brain Ki and Vp value for each subject. 
Discussion
PET has been employed to assess BBB integrity in patients with cerebral infarction, brain tumours and dementia.'9 -23 Recently, Brooks et a19 found normal BBB permeability in multiple sclerosis. However, their patients were in remission at the time of the study.
As frequently reported5 6 we also have observed a correlation between BBB alteration and clinical activity of multiple sclerosis. Both HVD-CT and PET studies clearly showed areas of BBB abnormalities in four of the eight patients examined during "acute exacerbation" before the initiation of antiinflammatory treatment. The negative findings in the remaining four patients could be explained by the fact that clinical exacerbations were associated with new symptoms reflecting an involvement of brain stem in two cases, and optic nerve and spinal cord in one case each. The absence of a pathological BBB increased permeability is justified in two patients examined during clinical remission and in five patients with chronic progressive multiple sclerosis whose clinical decline was shown mainly by signs and symptoms related to spinal cord involvement.
In the present series enhancing areas demonstrated by the HVD-CT scan were also detected by PET. However, a comparison of these two techniques was not the aim of this study and it is further limited at the present time since a single ring positron camera was Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and PET 1061 used. Although pathological studies have demonstrated that only "fresh plaques" show a BBB disruption, it is still unknown whether a relationship may exist between the entity of BBB damage and the "age" of the plaque. Theoretically one may argue that the temporal evolution of BBB damage in multiple sclerosis may reflect the underlying inflammatory reaction, thus resulting in a greater BBB alteration during the "peak" of the cellular infiltration. Future sequential quantitative PET studies will be necessary in order to clarify further this issue.
In conclusion, this study demonstrates that PET using 68-Ga-EDTA is a sensitive method for the detection and measurement of BBB dysfunction associated with multiple sclerosis and may be usefully employed to evaluate the effect of therapies on BBB abnormalities during the exacerbation of the disease. 
